Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
12,823,714
-
Share change
-
+32,313
-
Total reported value
-
$2,545,000
-
Put/Call ratio
-
0%
-
Price per share
-
$0.20
-
Number of holders
-
35
-
Value change
-
-$86,573
-
Number of buys
-
8
-
Number of sells
-
15
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q3 2022
As of 30 Sep 2022,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,823,714 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Tower Research Capital LLC (TRC), CITADEL ADVISORS LLC, MORGAN STANLEY, and EDMOND DE ROTHSCHILD HOLDING S.A..
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.